PROMOTION
A BREAKTHROUGH IN DERMAL FILLERS
Laboratories VIVACY discusses the versatility of its range of hyaluronic acid-based dermal fillers, and why this product is a must-have for any physician and patient
I
F YOU ARE LOOKING FOR safety, reliability and efficacy from your aesthetic treatments, you will naturally choose hyaluronic acid (HA), a gold- standard product in aesthetic medicine. It is now almost impossible to imagine basic skincare without it. But, with so many products on the market, it can be difficult to distinguish one HA from the other. The new generation of cosmetic consumers are both more informed and demanding than ever; they want safe, long-lasting, natural results with less downtime. Launched in 2008 by Laboratories VIVACY (France), STYLAGE® HA gels fulfil these criteria due to their innovative formulations, which ally quality, safety and efficiency. STYLAGE® is not just another HA.
It is now one of the leading brands in Europe that has achieved success without consumer marketing, but through experience and peer group recommendation.
What makes it stand out from the crowd? All HA fillers are cross-linked with a chemical to resist natural degradation and prolong duration. However, STYLAGE® uses a patented
interpenetrated cross-linked network (IPN-Like
Technology)
manufacturing process, which requires less chemical interference. The addition of mannitol to act against free radicals provides optimal resistance to degradation. Mannitol is a naturally occurring antioxidant found in the plant kingdom, and has been used in hospitals for rehydration and life support for many years. As a result, this innovative formula creates a safe, long-lasting product for all types of wrinkles, and all skin types. STYLAGE® has optimised elasticity
for easy modelling and reshaping, even for delicate areas like the nose, temples and hands. At the same time, it has high viscoelasticity for good filling capacity and natural aesthetic results thanks to its smoothing effect. STYLAGE® boasts a 12–18 month
duration with minimal swelling, including the mid-range medium viscosity products. STYLAGE® can be used to fill and smooth wrinkles, natural lip correction, volume restoration, hydration, chin remodelling, tear trough correction, neck, décolleté and hand rejuvenation. It is also possible to combine products for targeted treatment.
Named ‘BEST FILLER’ by the 116 ❚
Polish Society of Aesthetic Dermatologists (PSAD) in the Pearls of Aesthetic Dermatology contest in 2010, 2011, 2012, and voted BRONZE award in the ‘BEST PRODUCT INNOVATION’ category at the Aesthetic Industry Awards in 2012,
March 2013 |
prime-journal.com
the brand has built a solid reputation for its high quality and safety.
has optimised“STYLAGE® elasticity for
easy modelling and reshaping, even for
delicate areas like the nose, temples and hands.
”
Who is behind this breakthrough product? The STYLAGE® range comes from Laboratoires VIVACY, a French manufacturer specialising in the design, manufacturing and distribution of injectable medical devices for use anti-ageing medicine, particularly medical aesthetics and viscosupplementation. Founded in 2007 by specialists qualified in biopolymers and injectable product technologies, the company has acquired recognised expertise in dermal fillers based on HA and natural antioxidants, mannitol and sorbitol. The company has also created new technologies for use in ophthalmology (I.SPACE®), rheumatology (KARTILAGE®), and is currently developing in other medical viscosupplementation fields.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140